| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| GCR-H82E4 | Human | Biotinylated Human G-CSF R / CD114 Protein, Avitag™,His Tag |  |
|
|
| GCR-H5223 | Human | Human G-CSF R / CD114 Protein, His Tag |  |
|
|
| GCR-H5250 | Human | Human G-CSF R / CD114 Protein, Fc Tag |  |
|
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant human granulocyte colony-stimulating factor (Harbin Pharmaceutical Group Bioengineering) | Approved | Harbin Pharmaceutical Group | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Blau Pharmaceuticals) | Approved | Blau Pharmaceuticals | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Center of Molecular Immunology) | Approved | Center of molecular immunology | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (Emcure Pharmaceuticals) | Approved | Emcure | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Zydus Cadila) | Approved | Zydus cadila | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (Juta Pharma) | Approved | Juta Pharma | pegfilgrastim | ema | Juta Pharma GmbH | 2019-04-26 | Neutropenia | Details | ||
| Filgrastim biosimilar(Pooyesh Darou Pharmaceuticals) | G-CSF,G CSF,GCSF | Approved | Pooyesh Darou | Myelodysplastic syndrome (MDS), Neutropenia, Acute myeloid Leukemia (AML), Lymphoma | Details | |||||
| Filgrastim biosimilar (Hospira) | PLD-108,PLD108 | Approved | Hospira | filgrastim | ema | Pfizer Europe MA EEIG | 2010-06-07 | Neutropenia | Details | |
| Recombinant Human Granulocyte Colony-stimulating Factor (Wuzhong Group) | Approved | Jiangsu Wuzhong Pharmaceutical Suzhou Pharmaceutical Factory | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Apotex/Intas) | Approved | Intas Biopharmaceuticals, Apotex, SciVac Ltd | filgrastim | ema | Apotex Europe BV | 2013-10-17 | Neutropenia | Details | ||
| Filgrastim biosimilar (Veropharm) | Approved | Abbott | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Zenotech Laboratories) | Approved | Zenotech laboratories | Neutropenia, Cancer | Details | ||||||
| Filgrastim biosimilar (AqVida) | Approved | AqVida | Neutropenia | Details | ||||||
| Lipegfilgrastim | XM-22,XM22 | Approved | Teva | lipegfilgrastim | ema | Teva B.V. | 2013-07-25 | Neutropenia | Details | |
| Pegfilgrastim-jmdb | MYL-1401H,MYL1401H; MYL-1401-H | Approved | Biocon, Mylan | FULPHILA | fda | MYLAN GMBH | 2018-06-04 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Zydus Cadila) | Approved | Zydus cadila | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Pharmapark) | Approved | Pharmapark | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Elea) | Approved | Elea | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Chandra Bhagat Pharma) | Approved | Chandra Bhagat Pharma（CBC） | Cancer | Details | ||||||
| GCPGC | MG-1107 | Approved | Green Cross | Neutropenia | Details | |||||
| Filgrastim biosimilar (GeneScience Pharmaceuticals) | Approved | GeneScience Pharmaceutical (GenSci) | Recombinant Human Granulocyte Colony-stimulating Factor Injection | cfda | Neutropenia | 2015-08-18 | Neutropenia | Details | ||
| Filgrastim biosimilar (Chengdu Institute of Biological Products) | Approved | Chengdu Institute of Biological Products | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Shandong Quangang Pharmaceutical) | Approved | Shandong Quangang Pharmaceutical | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Sedico) | Approved | Sedico | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Xiamen Amoytop Biotech) | Approved | Xiamen Amoytop Biotech | Recombinant Human Granulocyte Colony-Stimulating Factor Injection | cfda | Neutropenia | 2015-09-24 | Neutropenia | Details | ||
| Pegfilgrastim biosimilar (Accord Healthcare) | Approved | Accord Healthcare, Intas Biopharmaceuticals | pegfilgrastim | ema | Accord Healthcare S.L.U. | 2018-09-21 | Neutropenia | Details | ||
| Pegfilgrastim biosimilar (Zydus-Cadila Group) | Approved | Zydus cadila | Neutropenia | Details | ||||||
| Recombinant human granulocyte colony-stimulating Factor (Shenzhen Xinpeng Bio-tech) | Approved | Shenzhen Xinpeng Biological Engineering | Recombinant Human Granulocyte Colony-stimulating Factor Injection | cfda | Neutropenia | 2015-06-01 | Neutropenia | Details | ||
| Filgrastim biosimilar (Nanogen) | Approved | Nanogen Biopharmaceutical Co | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Beijing SL Pharmaceutical) | Approved | Beijing ShuangLu Pharmaceutical | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Apexcela) | Leuco-Plus-300; SBS-6002 | Approved | Apexcela, Siam Bioscience | Neutropenia | Details | |||||
| Nartograstim | KW-2228; ND-28; PE-2601,KW2228 | Approved | Kyowa Hakko Kirin, Yakult | Nartograstim | 日本 | Neutropenia | 养乐多 | 1994-04-01 00:00:00.0 | Neutropenia | Details |
| Filgrastim biosimilar (SICOR Biotech) | Approved | Teva | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Dong-A) | DA-3030 | Approved | Dong-A Pharmaceutical | Neutropenia | Details | |||||
| Filgrastim biosimilar (Landsteiner) | Approved | Landsteiner Scientific | Neutropenia | Details | ||||||
| Filgrastim-sndz | EP-2006,EP2006 | Approved | Sandoz | filgrastim | ema | Hexal AG | 2009-02-06 | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Dong-A ST) | DA-3031 | Approved | Dong-A Pharmaceutical | Neutropenia | Details | |||||
| Filgrastim biosimilar (RPG Life Sciences) | Approved | RPG Life Sciences | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Hangzhou Jiuyuan Gene Engineering) | Approved | Hangzhou Jiuyuan Gene Engineering | Recombinant Human Granulocyte Colony Stimulating Factor Injection | cfda | Neutropenia | 2015-11-04 | Neutropenia | Details | ||
| Pegfilgrastim biosimilar (CinnaGen) | Approved | CinnaGen | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Siam Bioscience) | Approved | Siam Bioscience | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (Amega Biotech) | Approved | Amega Biotech | Neutropenia | Details | ||||||
| Filgrastim | KRN-8601; REC-G-CSF; r-metHuG-CSF; rhGCSF (Amgen/Kyowa Hakko Kirin),KRN8601 | Approved | Amgen, Kyowa Hakko Kirin | NEUPOGEN | fda | Neutropenia | AMGEN | 1991-02-20 | Neutropenia | Details |
| Pegfilgrastim biosimilar (Dr Reddy's Laboratories) | DRL_PG | Approved | Dr.Reddy's Laboratories | Neutropenia | Details | |||||
| Pegfilgrastim biosimilar (Nanogen Biopharmaceutical) | Approved | Nanogen Biopharmaceutical Co | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Dr Reddy's Laboratories) | Approved | Dr Reddys Laboratories | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (Cinfa Biotech) | B-12019,B12019; B 12019 | Approved | Cinfa Biotech, Mundipharma | pegfilgrastim | ema | To reduce the duration of neutropenia and the incidence of febrile neutropenia due to chemotherapy. |
Mundipharma Biologics S.L. | 2018-11-20 | Neutropenia | Details |
| Pegfilgrastim | KRN-125; R-1471; SD-01; SD/01 | Approved | Amgen, Kyowa Hakko Kirin | NEULASTA | fda | Neutropenia | AMGEN | 2002-01-31 | Neutropenia | Details |
| Filgrastim biosimilar (Qilu Pharmaceutical) | Approved | Qilu Pharmaceutical | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Biosidus) | Approved | Biosidus | Neutropenia | Details | ||||||
| Pegylated recombinant human granulocyte colony stimulating factor (CSPC Pharma) | Approved | China Shijiazhuang Pharmaceutical Group/CSPC | PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor Injection | cfda | Neutropenia | 2016-07-05 | Neutropenia | Details | ||
| Tbo-filgrastim | XM-02; TKN-732,XM02 | Approved | Teva, Nippon Kayaku | filgrastim | ema | AbZ-Pharma GmbH | 2008-09-15 | Neutropenia | Details | |
| Filgrastim biosimilar (Sudershan Biotech) | Approved | Sudershan Biotech Ltd | Neutropenia | Details | ||||||
| Lenograstim | rG-CSF | Approved | Chugai | Lenograstim | 日本 | Neutropenia | 中外制药 | 1991-10-04 00:00:00.0 | Neutropenia | Details |
| Filgrastim biosimilar (CIGB/Heber Biotec) | Approved | Center for Genetic Engineering and Biotechnology, Heber Biotec | Neutropenia | Details | ||||||
| Lenograstim biosimilar (Biosidus) | Approved | Biosidus | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (AryaTinaGene) | Approved | AryaTinaGene Biopharmaceuticals | Febrile neutropenia | Details | ||||||
| Filgrastim biosimilar (Zuventus Healthcare) | Approved | Zuventus Healthcare | Neutropenia | Details | ||||||
| Pegfilgrastim (Dompé Biotec) | Approved | Dompé Biotec | pegfilgrastim | ema | Dompé Biotec S.p.A. | 2002-08-22 | Neutropenia | Details | ||
| Pegfilgrastim biosimilar (Qilu Pharmaceuticals) | PEG-rhG-CSF (Qilu Pharmaceuticals) | Approved | Qilu Pharmaceutical | Pegylated Recombinant Human Granulocyte Colony-stimulating Factor Injection | cfda | Neutropenia | 2015-08-18 | Neutropenia | Details | |
| Recombinant human granulocyte colony-stimulating factor (Shandong Kexing Bioproducts Co Ltd) | Approved | Shandong Kexing Bioproducts Co., Ltd | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Unilab) | Approved | Unilab | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Biocon) | Approved | Biocon BioPharmaceuticals, Mylan | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Institute of Medical Biology Chinese Academy of Medical Sciences) | Approved | The Chinese academy of medical sciences institute of medical biology | Recombinant Human Granulocyte-Macrophage Colony Stimulating Factou Injection | cfda | Leucopenia, Myelodysplastic syndrome (MDS), Neutropenia | 2015-09-19 | Myelodysplastic syndrome (MDS), Leucopenia, Neutropenia | Details | ||
| Empegfilgrastim | BCD-017 | Approved | Biocad | Neutropenia | Details | |||||
| Filgrastim biosimilar (Fresenius Kabi Oncology) | Approved | Fresenius Kabi | Neutropenia | Details | ||||||
| Filgrastim biosimilar (RAS Lifesciences) | Approved | RAS Lifesciences | Neutropenia | Details | ||||||
| Pegfilgrastim-cbqv (Coherus BioSciences) | CHS-1701 | Approved | Coherus Biosciences | pegfilgrastim | ema | ERA Consulting GmbH | 2018-09-21 | Neutropenia | Details | |
| Filgrastim biosimilar (CJ Corp) | Approved | CJ, Reliance GeneMedix | Neutropenia | Details | ||||||
| Filgrastim biosimilar (NCPC GeneTech Biotechnology Development) | Approved | North China Pharmaceutical | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (Intas Biopharmaceuticals) | INTP-5 | Approved | Intas Biopharmaceuticals, Apotex | Neutropenia | Details | |||||
| Filgrastim biosimilar (Eurofarma) | Approved | Eurofarma | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Claris Lifesciences) | Approved | Claris Lifesciences | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Biolotus Biotech) | Approved | Biolotus | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Probiomed) | Approved | Probiomed | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Emcure Pharmaceuticals) | Approved | Emcure | Neutropenia | Details | ||||||
| Recombinant human granulocyte stimulating factor (CSPC Pharma) | Approved | China Shijiazhuang Pharmaceutical Group/CSPC | Recombinant Human Granulocyte Colony-stimulating Factor Injection | cfda | Neutropenia | 2015-02-04 | Neutropenia | Details | ||
| Filgrastim biosimilar (Lupin) | Approved | Lupin | Neutropenia | Details | ||||||
| Filgrastim biosimilar (PT Kalbe) | Approved | Kalbe Farma | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Pharmstandard/Masterclone/CJSC Generium) | Approved | Pharmstandard, CJSC Generium, Masterclone | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (Lupin) | Approved | Lupin | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Reliance Life Sciences) | Approved | Reliance Life Sciences | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (Harvest Moon Pharmaceuticals/PanPharmaceuticals) | Approved | Harvest Moon, PanPharmaceutical | Neutropenia | Details | ||||||
| Pegfilgrastim biosimilar (Sandoz) | LAEP-2006,LA-EP-2006 ,LA-EP2006 | Approved | Sandoz | pegfilgrastim | ema | Sandoz GmbH | 2018-11-22 | Neutropenia | Details | |
| Filgrastim biosimilar (Fuji Pharmaceutical/Mochida/Gene Techno Science) | FSK-0808; GBS-001 | Approved | Gene Techno Science, Mochida, Fuji Pharmaceutical | Filgrastim biosimilar (Fuji Pharmaceutical/Mochida/Gene Techno Science) | 日本 | Neutropenia | 持田制药,Fuji Pharmaceutical | 2012-11-21 00:00:00.0 | Neutropenia | Details |
| Filgrastim biosimilar (Laboratorios AC Farma) | Approved | Laboratorios AC Farma | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Laboratorio Varifarma) | Approved | Laboratorio Varifarma, Laboratorio Pablo Cassara | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Incepta Pharmaceuticals) | Approved | Incepta Pharmaceuticals | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Chalver Laboratorios) | Approved | Chalver Laboratorios | Neutropenia | Details | ||||||
| Recombinant human granulocyte colony-stimulating factor (Shanghai Sunway Biotech) | Approved | Shanghai Sunway Biotech | cfda | Neutropenia | 2015-06-29 | Neutropenia | Details | |||
| Mecapegfilgrastim | HHPG-19K | Approved | Jiangsu Hengrui Medicine | Mecapegfilgrastim Injection | cfda | Neutropenia | 2018-05-08 | Neutropenia | Details | |
| Filgrastim biosimilar (Amega Biotech) | Approved | Amega Biotech | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Neiss Labs) | Approved | Neiss Labs | Neutropenia | Details | ||||||
| Recombinant human granulocyte colony stimulating Factor (Beijing Four Rings Bio-Pharmaceutical) | Approved | Beijing Four Rings Biopharmaceutical | Neutropenia | Details | ||||||
| Filgrastim biosimilar (Accord Healthcare) | Approved | Accord Healthcare | filgrastim | ema | Accord Healthcare S.L.U. | 2014-09-17 | Neutropenia | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Interleukin-1 alpha (Amgen/Roche) | Phase Ⅱ | Amgen, Roche | Neutropenia, Thrombocytopenia, Radiation injuries, Hodgkin lymphoma, Melanoma | Details | |
| Albumin-granulocyte colony stimulating factor (Beijing BioFortune/Tianjin SinoBiotech) | rHSA/GCSF; SFR-9314 | Phase Ⅱ | Tianjin SinoBiotech, Beijing Bio-Fortune | Neutropenia | Details |
| Filgrastim biosimilar (Biogenomics) | Phase Ⅰ | Biogenomics | Neutropenia | Details | |
| Granulocyte colony-stimulating factor (Shire) | Phase Ⅰ | Shire | Neutropenia | Details | |
| Benegrastim | F-627; rh G-CSF Fc Fusion Protein | Phase Ⅲ | Xuhua Biological, Generon Corporation | Neutropenia | Details |
| Pegfilgrastim biosimilar (Pfenex) | Preclinical | Pfenex | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Virchow Group) | PEG Neutrogen | Phase Ⅰ | Virchow Group | Neutropenia | Details |
| Pegfilgrastim biosimilar (Siam Bioscience) | Preclinical | Siam Bioscience | Neutropenia | Details | |
| Filgrastim biosimilar (Adello Biologics) | BLA Filing | Adello Biologics | Neutropenia | Details | |
| Filgrastim biosimilar (Merck) | INS-19; MK-4214 | Phase Ⅲ | Insmed, Merck Sharp & Dohme | Neutropenia | Details |
| Pegnartograstim | RO-258315 | Phase Ⅰ | Roche | Stem cell mobilization | Details |
| Pegfilgrastim biosimilar (Fresenius SE) | MSB-11455 | Phase Ⅰ | Merck Serono | Cancer | Details |
| PEGylated G-CSF | BBT-015 | Phase Ⅰ | Bolder BioTechnology | Neutropenia, Acute radiation syndrome | Details |
| Pegfilgrastim biosimilar (Beijing SL Pharmaceutical) | Phase Not Specified | Beijing ShuangLu Pharmaceutical | Neutropenia | Details | |
| Filgrastim biosimilar (Bionaturis) | Preclinical | Bionaturis | Neutropenia, Lysosomal storage diseases | Details | |
| Filgrastim biosimilar(Shandong Xinshidai Biotech) | BLA Filing | Lunan Pharmaceutical Group Corporatio | Immunological disorders | Details | |
| GW-003 | GW-003 | Phase Ⅰ | Jiangsu T-mab BioPharma | Neutropenia | Details |
| Pegfilgrastim biosimilar (Pfizer) | HSP-130 | Phase Ⅱ | Pfizer | Neutropenia | Details |
| Pegfilgrastim biosimilar (Tianjin Pegylatt Biotechnology) | Phase Ⅰ | Institute of Process Engineering, Tianjin Pegylatt Biotechnology, Tianjin Institute of Pharmaceutical Research | Febrile neutropenia, Neutropenia | Details | |
| Pegfilgrastim biosimilar (Affiliated Hospital of North Sichuan Medical College) | Phase Not Specified | Affiliated Hospital of North Sichuan Medical College | Neutropenia | Details | |
| Filgrastim biosimilar (MenoGenix) | MNGX-100 | Phase Ⅰ | MenoGeniX | Menopausal symptoms | Details |
| Filgrastim biosimilar (Mycenax Biotech) | BLA Filing | Mycenax Biotech | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Merck) | MK-6302; INS-20 | Phase Ⅰ | Insmed, Merck Sharp & Dohme | Neutropenia | Details |
| Recombinant G-CSF (Yuhan) | Phase Ⅲ | Yuhan Corporation | Neutropenia | Details | |
| CSL-324 | CSL-324 | Phase Ⅰ | MuriGen, CSL | Palmoplantar pustulosis, Hidradenitis suppurativa, Inflammation, Rheumatoid arthritis (RA) | Details |
| Granulocyte colony stimulating factor (Xenetic Biosciences/SynBio) | SYN-20111504-RU | Phase Ⅱ | Lipoxen Technologies, Serum Institute of India, SynBio, Xenetic Biosciences | Neutropenia | Details |
| GX-G03 | G-CSF-hyFc; GCSF-hFc; GX-G03; GX-G3 | Phase Ⅱ | Genexine, Boryung, Ilkogen | Neutropenia | Details |
| GM-CSF / IL3 fusion protein | IND Filing | Shanghai Zhao'an Medical CO.TLD, Beijing Yiges Medical Technology Development Co., Ltd. | Unspecified | Details | |
| Eflapegrastim | HM-10460A; HNK-460; LAPS-GCSF; SPI-2012 | BLA Filing | Hanmi, Spectrum Pharmaceuticals | Neutropenia | Details |
| Pegfilgrastim biosimilar (Bio-Ker) | Phase Ⅰ | Bio-Ker | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Jiangsu Aosaikang Pharmaceutical) | Phase Ⅰ | Jiangsu Aosaikang Pharmaceutical | Neutropenia | Details | |
| Pegfilgrastim biosimilar (PharmaEssentia) | PEG-GCSF | Phase Ⅰ | PharmaEssentia | Neutropenia | Details |
| Filgrastim biosimilar (Tanvex BioPharma) | TX-01 | BLA Filing | Tanvex BioPharma | Neutropenia | Details |
| Pegfilgrastim biosimilar (Eurofarma) | Phase Ⅲ | Eurofarma | Breast cancer | Details | |
| Pegfilgrastim ANF | PEG-G-CSF-ANF | Phase Ⅱ | Prolong Pharmaceuticals | Neutropenia | Details |
| Filgrastim biosimilar (Bio-Ker) | BK-0023 | Phase Ⅲ | Bio-Ker | Neutropenia | Details |
| Pegfilgrastim biosimilar (Hangzhou Jiuyuan Gene Engineering) | Phase Ⅱ | Hangzhou Jiuyuan Gene Engineering | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Gedeon Richter) | RGB-02 | BLA Filing | Gedeon Richter | Neutropenia | Details |
| SBC-014 | AES-014; AVI-014; SBC-014 | Phase Ⅲ | Alexion Pharmaceuticals | Neutropenia | Details |
| Pegfilgrastim biosimilar (USV) | BLA Filing | USV | Neutropenia | Details | |
| pegfilgrastim biosimilar (NAL Pharma) | NAL-3760 | Preclinical | NAL Pharma | Neutropenia | Details |
| Balugrastim (CoGenesys) | CG-10639; ALB-rG-CSF; G-CSF-HAS; HSA-rG-CSF | Phase Ⅲ | CoGenesys, Teva | Neutropenia | Details |
| Milodistim (Amgen) | GM-CSF/IL-3；PIXY-321,PIXY 321 | Phase Ⅲ | Amgen, Wyeth | Neutropenia, Thrombocytopenia, Chemotherapy-induced thrombocytopenia | Details |
| Filgrastim biosimilar (Raichem Lifesciences) | Phase Not Specified | Raichem lifesciences | Neutropenia | Details | |
| SC-70935 | SC-70935 | Phase Ⅲ | Pharmacia Corporation | Neutropenia | Details |
| Pegfilgrastim biosimilar (Adello Biologics) | Phase Ⅰ | Adello Biologics | Neutropenia | Details | |
| Pegfilgrastim biosimilar (Shandong New Time) | Phase Ⅲ | Lunan Pharmaceutical Group Corporatio | Neutropenia | Details | |
| Y-branched pegylated recombinant human granulocyte colony stimulating factor | YPEG-rhG-CSF | Phase Ⅱ | Xiamen Amoytop Biotech, BioGeneric | Neutropenia | Details |
| Filgrastim biosimilar (Virchow Group) | Neutrogen | Phase Ⅲ | Virchow Group | Neutropenia | Details |
| Pegfilgrastim biosimilar (Reliance Life Sciences) | R-TPR-029 | Phase Ⅲ | Reliance Life Sciences | Neutropenia | Details |
This web search service is supported by Google Inc.
A-Z
